Clinical trial design and patient recruitment is inefficient and expensive for both academia and industry. Penn Medicine is participating in TriNetX, a global provider, pharma and CRO data network to advance our feasibility and recruitment capabilities with the goal of bringing new therapies to our patients faster.
TriNetX enables researchers to:
- Design efficient protocols with inclusion and exclusion criteria using real world patient data
- Find and recruit patients that match protocols
- Attract sponsored studies from leading pharma and CROs
- Collaborate with peer academic institutions through shared access to patient populations
Penn Medicine researchers can request access to TriNetX and corresponding training materials by contacting Patrick Sullivan.
If you already have access, you can login here.